UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40645 RYAN SPECIALTY HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 86-2526344 (State or Other Jurisdiction of ...

RYAN SPECIALTY REPORTS FIRST QUARTER 2024 RESULTS - Total Revenue grew 20.6% year-over-year to $552.0 million - First Quarter 2024 Highlights "We had a great start to 2024, driven by another quarter of double-digit organic growth and further enhancement of our margin profile," said Patrick G. Ryan, Founder, Chairman and Chief Executive Officer of Ryan Specialty. "Our exceptional performance was highlighted by 13.7% organic revenue growth, a 120-basis point expansion of our Adjusted EBITDAC margin, and 34.6% ...

Financial Performance and Growth - Net income increased by $106.6 million, from $56.6 million in 2021 to $163.3 million in 2022[392] - Net income for 2023 was $194.48 million, with a net income margin of 9.4%[407] - Adjusted EBITDAC for 2023 was $624.74 million, with an adjusted EBITDAC margin of 30.1%[407] - Adjusted net income for 2023 was $375.58 million, with an adjusted net income margin of 18.1%[410] - Net income for 2023 increased to $194.48 million, up 19.1% from $163.26 million in 2022[500] - Net income for 2022 was $194.48 million, compared to $61.05 million in 2021, representing a significant increase[506] - Total revenue growth rate (GAAP) for 2023 was 20.4%, with organic revenue growth rate (Non-GAAP) at 15.0%[396] - Revenue from the Top 100 retail broker trading firms grew faster than the company's organic revenue growth rate of 15.0% in 2023[336] - Total cash flows from operating activities in 2023 were $477.20 million, a 42.2% increase from $335.51 million in 2022[500] - Cash flows used in investing activities for 2023 were $476.23 million, primarily due to business combinations of $446.68 million[500] - Cash flows from financing activities in 2023 were negative $12.61 million, compared to positive $314.76 million in 2022[500] - Ending cash balance for 2023 was $1.76 billion, slightly down from $1.77 billion in 2022[500] - Total assets increased to $7,247.2 million as of December 31, 2023, compared to $6,383.7 million in 2022, driven by growth in goodwill, customer relationships, and other intangible assets[497] - Goodwill increased to $1,646.5 million as of December 31, 2023, from $1,315.0 million in 2022, reflecting acquisitions and adjustments[497] - Customer relationships grew to $572.4 million as of December 31, 2023, up from $457.1 million in 2022, indicating expansion in customer base and related intangible assets[497] - Total liabilities increased to $6,267.6 million as of December 31, 2023, from $5,565.9 million in 2022, primarily due to higher fiduciary liabilities and long-term debt[497] - Stockholders' equity rose to $979.6 million as of December 31, 2023, compared to $817.8 million in 2022, driven by retained earnings and additional paid-in capital[497] - Retained earnings increased to $114.4 million as of December 31, 2023, from $54.0 million in 2022, reflecting improved profitability[497] - Non-controlling interests grew to $419.9 million as of December 31, 2023, from $339.4 million in 2022, indicating increased equity participation from minority stakeholders[497] - Total stockholders' equity increased to $979.64 million in 2022 from $817.81 million in 2021[506] Cost Management and Restructuring - The ACCELERATE 2025 program is expected to generate annual savings of approximately $50.0 million by 2025, with cumulative one-time charges of $90.0 million through 2024[326] - The company incurred restructuring expenses of $48.37 million in 2023, including $25.99 million for operations and technology optimization[581] - Restructuring and related expense for 2023 was $49.28 million, up from $5.72 million in 2022[407] - Acquisition-related expense for 2023 was $23.27 million, a significant increase from $4.6 million in 2022[407] - Non-cash equity-based compensation in 2023 was $69.74 million, down 10.0% from $77.48 million in 2022[500] - Depreciation expense increased to $9.04 million in 2023, up 58.8% from $5.69 million in 2022[500] - Amortization expense for 2023 was $106.80 million, a 3.1% increase from $103.60 million in 2022[500] - Operating lease costs for 2023 totaled $36.9 million, up from $32.8 million in 2022, reflecting increased leasing activity[590] - The present value of operating lease liabilities as of December 31, 2023, was $175.8 million, with total undiscounted future lease payments of $220.5 million[590] Revenue and Income Sources - The company's revenue is derived from net commissions and fees, which are calculated as a percentage of total insurance policy premiums, with additional contingent or volume-based commissions[345] - Fiduciary investment income is generated from interest earned on insurance premiums and surplus lines taxes held in fiduciary accounts[348] - Net commissions and policy fees revenue is recognized when an insurance policy is bound and issued, net of estimated policy cancellations[519] - Binding Authority revenue includes insurance commissions, supplemental commissions, and contingent commissions from carriers[524] - Approximately 3% of the company's revenues for the year ended December 31, 2023, were generated from activities in the United Kingdom, Europe, Canada, and Singapore[460] - Approximately 3% of the company's revenues for 2023 and 2022 were generated outside the United States, exposing it to foreign exchange rate fluctuations[200] Tax and Regulatory Matters - Income tax expense increased by $11.0 million, from $4.9 million in 2021 to $15.9 million in 2022, due to higher pre-tax book income[391] - Income tax expense for 2023 was $43.4 million, with an effective tax rate of 18.2%, compared to $15.9 million and 8.9% in 2022[670] - The company recorded a non-cash deferred income tax expense of $18.4 million due to Common Control Reorganizations (CCRs) in 2023[676] - The company recognizes a liability on the Consolidated Balance Sheets based on the undiscounted estimated future payments under the Tax Receivable Agreement (TRA)[428] - The company recognized $358.9 million and $295.3 million of liabilities relating to obligations under the Tax Receivable Agreement (TRA) as of December 31, 2023, and 2022, respectively, based on the assumption of sufficient future taxable income[454] - The company accounts for income taxes under the asset and liability method, recognizing deferred tax assets and liabilities for future tax consequences[555] - The company accounts for uncertain tax positions using a two-step approach, recognizing tax benefits when more likely than not to be sustainable upon examination[557] - The company has $2.9 million in foreign tax credit carryforwards that will begin to expire in 2031, with a full valuation allowance recorded against this deferred tax asset[672] - Changes in tax laws or regulations could materially increase corporate taxes and adversely affect the company's financial condition or results of operations[226] - The OECD/G-20 Inclusive Framework on BEPS may lead to a global minimum tax and changes in profit allocation rules, potentially increasing the company's effective tax rate and cash tax liabilities[228] - Unanticipated changes in effective tax rates or adverse outcomes from tax audits could adversely affect the company's operating results and financial condition[265] Legal and Regulatory Risks - The company is subject to various legal and regulatory oversight, including data privacy laws, cybersecurity regulations, and compliance with HIPAA, which could increase costs and limit growth[202][206][208] - The company faces potential liability from E&O claims and other legal proceedings, which could adversely affect its financial position and reputation[218] - The company holds client funds and surplus lines taxes, exposing it to complex fiduciary regulations and potential fines or penalties for mismanagement[220] - The company relies on common law trademark protection for key brand names like "Ryan Specialty" and "RT Specialty," which could be challenged or infringed upon, potentially harming its brand value[223] - Compliance with public company regulations has increased legal and financial compliance costs and may divert management's attention from revenue-generating activities[273] - The company's forum selection provisions in its certificate of incorporation may discourage lawsuits against it or its directors and officers[279] - The company's certificate of incorporation designates the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation, potentially limiting stockholders' ability to obtain a favorable judicial forum for disputes[279] Debt and Financing - The company had $1,596.4 million of outstanding principal on Term Loan borrowings as of December 31, 2023, with interest subject to a 0.75% floor and exposure to Adjusted Term SOFR interest rate changes[463] - The company's indebtedness is largely floating rate, and elevated or increasing interest rates could lead to higher interest expenses[233] - Inability to make scheduled payments on indebtedness could result in default, foreclosure, or bankruptcy[235] - The company may need to raise additional funds, and failure to do so could harm its competitive position and results of operations[242] - The Tax Receivable Agreement may require accelerated payments in certain circumstances, potentially exceeding actual tax benefits realized[257] - Cash flows used by financing activities in 2023 were $12.6 million, a decrease of $327.4 million compared to 2022[433] - Total projected future cash outflows for long-term incentive compensation agreements are $7.27 million, with $6.73 million expected in 2026[438] Market and Economic Risks - The E&S market saw $80 billion in insured catastrophe losses in 2023, driven by 21 severe convective storm events above $1 billion in losses, totaling $58 billion[341] - The company faces risks from potential decreases in insurance premiums or commission rates, which could lead to revenue reductions or expenses[163] - The company's inability to achieve the intended results of the ACCELERATE 2025 program could impact its business, financial condition, and results of operations[182] - The company's operating results and stock price may be impacted by changing economic conditions, including inflationary pressures and interest rate volatility[287] - The company's stock price may be influenced by investors' perception, events beyond its control (e.g., weather, war, health crises), and any default on its indebtedness[287] - The company's quarterly operating results and stock price may fluctuate due to market conditions, new product introductions, regulatory developments, and other factors[285] - Sales of a large number of Class A common stock shares in the public market could reduce the trading price of the stock[281] - The company has filed registration statements to register shares of Class A common stock and other equity securities issued under incentive plans, which may be freely sold in the public market[281] Corporate Governance and Stock Structure - The Director Nomination Agreement with the Ryan Parties grants them significant influence over board nominations, potentially resulting in disproportionate representation[270] - The company's dual-class common stock structure and other governance provisions could discourage proxy contests and affect stockholder influence over corporate actions[276] - The company may issue preferred stock in the future, which could delay or prevent a change in control and adversely affect the market price and rights of Class A common stock holders[283] - The company's preferred stock could be issued with voting, liquidation, dividend, and other rights superior to Class A common stock[283] - The company's operating results may be affected by the departure or addition of key personnel[285] Acquisitions and Investments - The company signed a definitive agreement to acquire Castel Underwriting Agencies Limited, with the transaction expected to close in the first half of 2024[331] - Internally developed software in development increased to $18.1 million in 2023, up from $11.2 million in 2022, indicating ongoing R&D investments[587] - The fair value of the interest rate cap as of December 31, 2023, was $29.7 million, down from $45.9 million in 2022, reflecting changes in market conditions[643] Compensation and Equity - Unvested Restricted Stock Units (RSUs) at the end of 2023 totaled 3,359,778, with a weighted average grant date fair value of $23.07[617] - Incentive RSUs granted in 2023 totaled 921,288, with a weighted average grant date fair value of $41.37[617] - Outstanding Incentive Options at the end of 2023 totaled 165,684, with a weighted average exercise price of $34.39[620] Receivables and Liabilities - The company's receivables are shown net of an allowance for credit losses, estimated based on historical write-offs and current economic conditions[529] - Receivables increased to $294.2 million as of December 31, 2023, up from $231.4 million in 2022, reflecting growth in commissions and fees receivable[584] - The company records liabilities for loss contingencies when probable and reasonably estimable, with significant management judgment required[552] - The company has an ownership interest in three entities holding segregated account protected cell captives, with only the activity of the regulated Core Companies recorded in consolidated financial statements[551] - Loss on Tax Receivable Agreement in 2023 was $11.17 million, more than double the $5.55 million in 2022[500] - Deferred income tax expense from common control reorganizations in 2023 was $18.36 million, a new expense item not present in 2022[500]

Ryan Specialty Holdings, Inc. (NYSE:RYAN) Q4 2023 Earnings Conference Call February 27, 2024 5:00 PM ET Company Participants Pat Ryan – Founder, Chairman and Chief Executive Officer Tim Turner – President Jeremiah Bickham – Chief Financial Officer Miles Wuller – Chief Executive Officer, RSG Underwriting Managers Conference Call Participants Elyse Greenspan – Wells Fargo Mike Zaremski – BMO Capital Markets Meyer Shields – KBW Rob Cox – Goldman Sachs Bill Carcache – Wolfe Research Mike Ward – Citi Ryan Tunis ...

RYAN SPECIALTY REPORTS FOURTH QUARTER 2023 RESULTS; INITIATES QUARTERLY DIVIDEND - Total Revenue grew 22.5% year-over-year to $532.9 million - - Adjusted EBITDAC grew 24.6% year-over-year to $158.6 million - - Adjusted Net Income increased 29.6% year over year to $95.7 million, or $0.35 per diluted share - FEBRUARY 27, 2024 | CHICAGO, IL — Ryan Specialty Holdings, Inc. (NYSE: RYAN) ("Ryan Specialty" or the "Company"), a leading international specialty insurance firm, today announced results for the fourth q ...

Financial Data and Key Metrics - Total revenue grew by 21.8% YoY to $502 million, with organic revenue growth of 14.7% [7][27] - Adjusted EBITDAC increased by 25.8% YoY to $147 million, with an adjusted EBITDAC margin improvement of 90 basis points to 29.3% [36] - Net income for Q3 2023 was $16 million, impacted by a one-time non-cash deferred tax expense of $0.04 per diluted share due to the Socius acquisition [28] - The company raised its full-year 2023 organic revenue growth guidance to 13.5%-14.5% and adjusted EBITDAC margin guidance to 29.5%-30.0% [37] Business Line Performance - Wholesale brokerage specialty saw strong growth, driven by property and casualty lines, with significant contributions from the Socius acquisition [21][23] - Underwriting Management specialty performed well, with growth driven by rate increases, new initiatives like excess casualty, and profit commissions [24] - Binding authority specialty continued its strong performance, with opportunities for panel consolidation and long-term growth [31] Market Trends and Dynamics - The E&S market remained robust, with increased flow of business due to complex weather, legal environments, and reduced risk appetite in the admitted market [19][20] - Property pricing and submission flow were key drivers of growth, with strong rate momentum in property lines, though public company D&O and Cyber saw exceptions [25] - Casualty lines, particularly transportation and habitational, experienced higher flow into the E&S market due to social inflation and reserving issues [22][54] Strategic Direction and Industry Competition - The company continues to execute its M&A strategy, focusing on high-quality specialty distributors and expanding its total addressable market in specialty insurance [9][10] - Recent acquisitions, including AccuRisk, have strengthened the company's employee benefits platform, with a focus on medical stop loss and integrated health solutions [11][12] - The company remains disciplined in its M&A approach, targeting firms with higher growth and long-term margin potential [13][14] Management Commentary on Operating Environment and Outlook - Management highlighted the uncertain macroeconomic and geopolitical environment but expects favorable specialty insurance market dynamics to persist [17] - The company is well-positioned to capitalize on E&S market tailwinds through its flexible business model and specific growth lines [18] - The ACCELERATE 2025 program is expected to generate $50 million in annual savings by 2025, with cumulative special charges of $90 million through 2024 [15][29] Other Important Information - The company made targeted investments in talent during the quarter to enhance capabilities in current and developing lines of business [14] - The Socius acquisition was restructured for tax efficiency, resulting in a one-time non-cash deferred tax expense but no expected cash impact [28] Q&A Session Summary Question: Organic growth guidance and Q4 expectations [39] - Q4 is seasonally strong, with potential upside in property business, though the guidance reflects measured assumptions [40] Question: Incremental savings from the ACCELERATE 2025 program [41] - The full $50 million in savings will be realized in 2025, with more savings flowing through in 2024 [41] Question: M&A pipeline and valuation trends [42][43] - Larger deals are defined as those over $400 million, with valuations remaining consistent for high-quality companies [42][43] Question: Expansion of total addressable market (TAM) [46][47] - The company aims to expand TAM significantly and is prepared to deploy all available capital, including potential debt, for strategic acquisitions [46][47] Question: Drivers of growth in binding authority and Underwriting Management [50][51] - Growth is driven by rate opportunities, new product launches, and profit commissions from prior soft market cycles [50][51] Question: Sustainability of property flow into the E&S market [56][61] - The company expects continued strong demand for E&S products due to global warming impacts and structural housing shortages [61][62] Question: Impact of larger brokers entering the wholesale space [63][64] - The company believes its independence and specialized expertise differentiate it from potential new entrants [63][64] Question: Talent retention and productivity [66][67] - The company's culture and platform enable high talent retention and productivity increases for new hires [66][67] Question: Transactional business trends [68] - Global M&A volumes remain under pressure, but the company is offsetting this through geographic and product expansion [68] Question: Assumptions for supplemental and contingent commissions in guidance [71][72] - Supplemental and contingent commissions are not included in organic growth calculations but are factored into margin guidance [71][72] Question: Casualty market trends and social inflation [73][74] - The company sees steady increases in high-hazard casualty business, driven by transportation, habitational, and consumer product liability [73][74] Question: Margin expectations for Q4 [77] - Lower margins in Q4 are expected due to hiring and continued investments in the business [77] Question: Integration of benefits businesses [79][80] - The three benefits businesses complement each other, with AccuRisk adding capabilities in group captives and integrated health plans [79][80] Question: Business mix changes YoY [92] - Public D&O remains a headwind, but its impact has lessened compared to the previous year [92][97]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact name of registrant as specified in its charter) For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 86-2526344 (State or Other Jurisdiction of Incorporation or Organization) For the transition period from to Commission File Number: ...

Financial Data and Key Metrics - Total revenue grew 19.1% YoY to $585 million, driven by 16.1% organic growth [5][32] - Adjusted EBITDAC increased 16.9% YoY to $194 million, with a margin decline of 60 bps to 33.2% [25] - Net income for Q2 2023 was $84 million, or $0.26 per diluted share, while adjusted net income was $124 million, or $0.45 per diluted share [25] - The company expects GAAP interest expense of $31 million in Q3 and $29 million in Q4 [22] Business Line Performance - Property and casualty lines showed strong growth, particularly in transportation, driven by social inflation and carrier rate increases [21][24] - The Binding Authority specialty saw solid growth in traditional binding and personal lines despite capacity constraints [29] - Public company D&O, transactional liability, and construction-related lines faced headwinds, with modest growth expected in H2 [30] - The Wholesale Brokerage specialty performed well, with property and casualty lines benefiting from market conditions and higher reinsurance costs [45][46][47] - The Underwriting Management specialty delivered strong results, particularly in property, casualty, and reinsurance [48] Market Performance - The E&S (Excess and Surplus) market remained robust, with increased flow due to conservative appetites, rate increases, and tighter limit management [13][24][27] - California, a significant E&S market, showed double-digit growth in recent months, driven by personal lines and property [84][85] - The cyber market experienced rate deceleration, particularly in public D&O and excess layers, but remains a growth opportunity [42][86][112] Strategic Direction and Industry Competition - The company completed three strategic acquisitions in July, adding $40 million in annual revenue and expanding capabilities in professional lines, cyber, and benefits [7][8][17] - The ACCELERATE 2025 program is on track to deliver $35 million in annual savings by 2025, with $17 million in charges incurred in Q2 [12][51] - The company continues to invest in talent and innovation, particularly in areas like cat property and transportation, to capture market share and drive long-term growth [11][13][15] - The benefits market is a key focus, with acquisitions in medical stop-loss insurance and plans to expand into integrated health solutions [16][17][72] Management Commentary on Operating Environment and Outlook - Management expects favorable specialty insurance market dynamics to persist, with 2023 projected to be another strong year [14] - The company raised its full-year organic revenue growth guidance to 13.0%-14.5%, up from 10.5%-13.0%, while maintaining adjusted EBITDAC margin guidance of 29.0%-30.0% [52][55] - The E&S market is expected to remain a significant driver of growth, with flow into the non-admitted market outpacing rate increases [49] Other Key Information - The company paid for three acquisitions at the beginning of Q3, reducing operating funds relative to the Q2 balance sheet [22] - Fiduciary investment income partially offset margin pressures from hiring and T&E normalization [25][33] - The company remains disciplined in M&A, focusing on cultural fit, strategic alignment, and accretion [10] Q&A Session Summary Question: Updated organic growth guidance and property concentration - Q2 is the highest property concentration quarter, with Q4 being the next highest but not expected to match Q2 growth [36] - The company expects H2 growth to mirror H1, with strong contributions from casualty lines [55] Question: M&A pipeline and margin impact - The M&A pipeline remains robust, with discussions ongoing in the benefits market [57] - Acquisitions are expected to have a neutral margin impact, with no significant changes to seasonality or EBITDAC [59][74] Question: Cyber market dynamics - Cyber remains a growth opportunity despite rate deceleration, with the company well-positioned in binding authorities and MGUs [86][112][117] Question: California market and property E&S capabilities - The company is well-positioned in California, with strong capabilities in property and casualty, including a new high-net-worth personal lines facility [85][107][108] Question: ACCELERATE 2025 savings timing - Savings from the program are expected to materialize in 2024, with the full $35 million annual impact in 2025 [104] Question: Fiduciary assets and seasonality - Fiduciary asset fluctuations are normal and driven by timing factors, with no material changes to DSO or business mix [69] Question: Competitor T&E spending and growth opportunities - No significant pullback in competitor T&E spending has been observed, with the market remaining highly competitive [90]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40645 RYAN SPECIALTY HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 86-2526344 (State or Other Jurisdiction ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40645 RYAN SPECIALTY HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 86-2526344 (State or Other Jurisdictio ...